Zuellig Pharma

We are delighted to announce that Zuellig Pharma has been named the winner of the UN Women 2024 Thailand WEPs Awards in the Gender-Inclusive Workplace category, recognising our unwavering commitment to promoting gender equality and fostering inclusion in society.   Managing Director of Zuellig Pharma Thailand Pucknalin Bulakul accepted the award on behalf of the company at the bi-annual Women’s Empowerment Principles (WEPs) Awards event in Thailand last Friday, which was organised by UN Women Asia and the Pacific and supported by the Australian Department of Foreign Affairs and Trade.   This award is a testament to our efforts in fostering an inclusive and equitable work environment for our employees, such as through initiatives to actively support and create career pathways for employees of any gender to progress, close wage gaps and advocate for flexible working arrangements.   At Zuellig Pharma, we recognise that diversity is more than a metric; it is a vital asset that drives innovation and success. We are committed to enhancing our efforts in creating a more equitable workplace for all, while pushing boundaries to make a lasting impact on gender equality.   #2024ThailandWEPsAwards #GenderActionLab #ZuelligPharmaThailand #DiversityEquityInclusion #GenderEquality

Earlier this month, we partnered with the Singapore Economic Development Board (EDB), LogiSYM and SAAA@Singapore to organise the SAAA-LogiSYM Supply Chain Day 2024. With increased disruptions in supply chains in recent years, the event provided an opportunity for industry leaders and professionals to explore new and better ways to organise supply chains. Guest of Honour Senior Minister of State, PMO and Deputy Secretary General, National Trades Union Congress (NTUC) Desmond Tan gave an opening speech emphasising the significance of innovation and better resource management to create more efficient, sustainable supply chains, while commending Zuellig Pharma on our commitment and efforts in driving this agenda in our sector. Decarbonising the logistics and transport sector is not only vital for environmental sustainability but also crucial for the economic health of countries and organisations. On behalf of Zuellig Pharma, Vice President of Corporate Affairs Jean-Gaetan Guillemaud led a panel session featuring leaders from GSK, Enterprise Singapore, IDC Asia/Pacific and SAAA@Singapore, as they discussed the importance of industry-government partnerships to decarbonise the logistics and transport sector. A key highlight was the Zuellig Pharma Supplier Sustainability Awards, where we recognised and celebrated suppliers who are committed to sustainable and responsible practices. In an industry where 80% of carbon emissions originate from the supply chain, supplier engagement is critical to drive sustainable outcomes. We were pleased to announce the winner and runner-up, Aeris Dynamics Pte. Ltd. and Multifiling Mitra Indonesia (Iron Mountain) respectively, after evaluating over 40 shortlisted suppliers based on extensive criteria such as environmental impact, corporate social responsibility, and ethical sourcing. Congratulations to all suppliers who made it to the Top 5, including Sri Pushpam Recycling Sdn. Bhd., Metrologie Concepts Solutions, and Yuan Ting Technology—thank you for your dedication to driving sustainability in our supply chain. Through partnerships with key stakeholders such as suppliers and government bodies, Zuellig Pharma is committed to bringing about meaningful change in the supply chain industry for a more sustainable future.   #SustainabilityAtZP #SupplyChain #Sustainability #ESG #SustainableProcurement

Our team in Malaysia was pleased to be a part of the IMU University Graduate Career Fair 2024 last month, where they provided career guidance and valuable insights to pharmacy, medicine, and health science students aspiring to build meaningful careers in healthcare. With a comprehensive Learning & Development programme in Malaysia to support the career development of young talents within Zuellig Pharma, we are committed to nurturing the next generation of healthcare leaders and offering a myriad of growth opportunities across various disciplines. This successful event marks our second year of partnership with IMU University. We look forward to strengthening our collaboration with local universities and industry associations to cultivate emerging talents in healthcare and establish Zuellig Pharma as the employer of choice for graduates. Connect with our Malaysia team at the Sunway University iNET 2024 and Pharmaceutical Association of Malaysia Career Day 2024 next month, or visit our Careers page to learn how you can be part of a passionate team that makes a difference every day for the communities we serve: https://lnkd.in/gyTf8QN6 #ZuelligPharmaMalaysia #GraduateCareers #CareerFair #HealthcareCareers

The equitable distribution of medicines and their accessibility are critical to the resilience of the healthcare system. However, disparities in access and equity continue to exist and these are pertinent to address, especially as healthcare disruptions can negatively impact an economy's public health and patient care.   In recent years, supply chain risk management practices have been revolutionised by technology, with new innovations and risk management solutions reducing accessibility concerns through real-time insights and data-driven mitigation strategies. Read this BioSpectrum Asia article to learn how Zuellig Pharma harnesses the transformative potential of disruptive technologies to enhance supply chain resilience, agility, and responsiveness to risks, developing a connected pharmaceutical ecosystem through innovative digital platforms: https://lnkd.in/d3T5TEWv   #HealthcareAccess #SupplyChainRiskManagement #HealthcareInnovation #Sustainability #ESG 

Zuellig Pharma recently celebrated Integrity Week, emphasising our commitment to upholding the highest standards of integrity and excellence. Integrity Week is part of our ongoing employee engagement efforts on the four pillars within our Sustainability Framework. Kicking off the week was an insightful webinar on “Compliance Challenges and Trends for the Pharma Industry in the Digital Space”, featuring panelists from Bayer, MENARINI Group, Thailand’s Pharmaceutical Research and Manufacturers Association (PReMA), The Hong Kong Association of the Pharmaceutical Industry and TRANSFORMING.LEGAL. Moderated by our Regional Head of Compliance Redentor Romero, the discussion explored the evolving compliance landscape and focused on trending topics such as social media, healthcare professional influencers, generative AI, and other digital advancements. Additionally, the “Compliance in Action” video series launched during the week featured various Zuellig Pharma leaders talking about essential compliance topics relevant to our operations. The engaging series aimed to deepen employees’ understanding on the importance of ethical business conduct within their individual roles. Culminating the week’s events was the launch of the Manager’s Ethics & Compliance Playbook, a key resource equipping managers with the necessary tools and strategies to reinforce key ethics and compliance principles in their day-to-day interactions. At Zuellig Pharma, we believe in building a culture that empowers our employees to uphold the highest standards of integrity and excellence as we deliver on our commitments to our stakeholders. #EthicsAndCompliance #Integrity #Sustainability #ESG #EmployeeEngagement

Throughout the month of August, over 2,000 employees from our offices and branches across Indonesia got together to commemorate the nation’s 79th Independence Day with our “Share of Fun x Independence Day 2024” programme. They had the opportunity to participate in various exciting staff activities, from team games to cultural fashion shows, aimed at celebrating this momentous occasion and building team camaraderie and engagement. Serving the Indonesian healthcare market since 1985, Zuellig Pharma has established a network that covers more than 60,000 medical facilities across 434 cities. We remain committed to our purpose of making healthcare more accessible, as we provide world-class distribution, digital and commercial services to support the growing healthcare needs of Indonesia. PT Anugerah Pharmindo Lestari #IndonesiaIndependenceDay #EmployeeEngagement #TeamBonding

This National Women's Health and Fitness Day, we turn the spotlight on two diseases posing a higher risk in women—osteoporosis and breast cancer—and emphasise the urgent need to ensure every woman has better access to early detection, timely diagnosis, and quality care.   Read on as three female leaders from ZP Therapeutics, Zuellig Pharma’s commercialisation division, share their thoughts and experiences in bridging this gap to make healthcare more accessible to women in Asia.   Sunaiyanaa Kidkasetpaisal Fazlin Azura Azlan Ninia Torres   #AwarenessWithZP #ZPTherapeutics #WomensHealthAndFitnessDay #WomensHealth #Osteoporosis #BreastCancer

We are excited to announce that Zuellig Pharma has achieved another milestone in the 2024 EcoVadis assessment, earning our fourth consecutive Platinum medal with a score of 90 out of 100. This achievement places us among the top 60 companies worldwide, out of 130,000 respondents, and the first organisation in Asia Pacific to reach this level.   With our strong performance in the CDP and a 38% reduction in carbon emissions in 2023, our 8-point improvement in our EcoVadis assessment from last year further solidifies our commitment to sustainability.   Key initiatives, such as our "Worker Voice" social audit programme, supplier engagement efforts, and HSSE-related certifications, have been instrumental in achieving this score. This accomplishment is a testament to the commitment and hard work of our teams across the organisation, and we remain steadfast in driving continued progress on our sustainability journey.   Together, we hope to pave the way for a more sustainable future in healthcare.   #Sustainability #ESG #SustainabilityatZP #BuildingAHealthierFutureForAsia

Zuellig Pharma was pleased to be a part of the 2024 SDG Asia Forum organised by the Taiwan Institute for Sustainable Energy in Taiwan last month, which provided a platform to discuss the latest sustainability trends and best practices, as well as the role that businesses, governments, and academia can play in alignment with the Taiwan government’s goal of achieving net-zero carbon emissions by 2050. Managing Director of Zuellig Pharma Taiwan John Chou gave a keynote presentation on "Sustainability in the Healthcare Supply Chain", highlighting Zuellig Pharma’s commitment to sustainability and the key carbon reduction initiatives that the Taiwan team has implemented, from our innovative eco-friendly packaging solution eZCooler to Taiwan’s first electric trucks for cold-chain logistics. Emphasising the importance of stakeholder collaboration, John also cited plans to partner with medical institutions to develop sustainable packaging initiatives to further reduce environmental impact. This was followed by an insightful panel discussion, where John and esteemed leaders from the Taipei Medical University, Ministry of Health and Welfare, and Lotus Pharmaceutical Co., Ltd discussed industry challenges and opportunities to enable a more sustainable healthcare supply chain through partnerships and digital transformation. With Respecting the Environment as one of the pillars in our Sustainability Framework, Zuellig Pharma remains committed to reducing our carbon footprint and influencing climate action in our supply chain. #ZuelligPharmaTaiwan #Sustainability #SustainabilityinHealthcare #RespectingTheEnvironment #CarbonReduction

Asia is a large and diverse region with a complex healthcare landscape that continues to witness significant changes driven by demographic shifts, urbanisation, and rising non-communicable diseases.   Focusing on key trends in drug innovation and commercialisation, particularly in areas such as diabetes, obesity, and cardiovascular health, Executive Vice President of ZP Therapeutics, Zuellig Pharma, Rehan S., speaks with BioPharma APAC to share his insights on the challenges and opportunities within this diverse and complex region.   Read the interview to learn more about how ZP Therapeutics, Zuellig Pharma's commercialisation division, remains at the forefront of addressing these challenges through strategic partnerships, innovative approaches, and a deep understanding of the region’s unique needs: https://lnkd.in/dKnAbdEs   #ZPTherapeutics #HealthcareCommercialization #MakingHealthcareMoreAccessible